Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.720
+0.320 (9.41%)
At close: Sep 5, 2025, 4:00 PM
3.790
+0.070 (1.88%)
After-hours: Sep 5, 2025, 7:59 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $487.70 million as of September 5, 2025. Its market cap has decreased by -4.04% in one year.
Market Cap
487.70M
Enterprise Value
505.68M
1-Year Change
-4.04%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $487.70M, a decrease of -70.03%. That is a compound annual growth rate of -34.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 487.70M | 30.90% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |